Thrombocytopenia: Definition, Diagnosis, and Management
Thrombocytopenia is defined as a platelet count less than 150 × 10³ per μL, characterized by decreased platelets in peripheral blood that can result from decreased production, increased destruction, splenic sequestration, or dilution. 1
Clinical Presentation and Significance
The severity of thrombocytopenia correlates with bleeding risk:
- >50 × 10³/μL: Generally asymptomatic 1
- 20-50 × 10³/μL: Risk of mild bleeding with skin manifestations (petechiae, purpura, ecchymosis) 1
- 10-20 × 10³/μL: Increased bleeding risk
- <10 × 10³/μL: High risk of serious bleeding, including gastrointestinal hemorrhage, extensive skin/mucosal bleeding, or intracranial hemorrhage 2, 1
Etiology
Thrombocytopenia can result from four primary mechanisms:
Decreased platelet production:
- Bone marrow disorders
- Nutritional deficiencies (B12, folate)
- Medications/chemotherapy
- Viral infections
Increased platelet destruction:
- Immune thrombocytopenia (ITP)
- Drug-induced immune thrombocytopenia
- Heparin-induced thrombocytopenia (HIT)
- Thrombotic microangiopathies
Splenic sequestration:
- Liver disease with portal hypertension
- Hypersplenism
Dilutional or artifactual:
- Massive transfusion
- Pseudothrombocytopenia (EDTA-induced platelet clumping) 2
Diagnostic Approach
When thrombocytopenia is detected:
Confirm true thrombocytopenia:
Determine if acute or chronic:
- Review previous platelet counts 1
- Acute severe thrombocytopenia may require emergency hospitalization
Essential laboratory evaluation:
- Complete blood count with differential
- Peripheral blood smear examination
- Consider additional tests based on clinical suspicion:
- Bone marrow examination (if persistent or associated with other abnormalities)
- HIV and HCV testing
- Vitamin B12 and folate levels
- Iron studies
- Liver function tests
- Lactate dehydrogenase (LDH)
- Autoimmune markers (ANA, antiphospholipid antibodies)
- Flow cytometry for suspected hematologic malignancies 3
Management Considerations
Management depends on the underlying cause, severity of thrombocytopenia, and presence of bleeding:
Observation:
- Appropriate for asymptomatic patients with platelet counts >50 × 10³/μL 1
Treat underlying cause:
- Discontinue suspected causative medications
- Treat infections
- Address nutritional deficiencies
- Manage liver disease 3
Specific treatments for immune thrombocytopenia:
Platelet transfusions:
- Recommended for:
- Active hemorrhage
- Platelet counts <10 × 10³/μL
- Before invasive procedures (target count depends on procedure)
- Note: Platelet transfusions may be contraindicated in certain conditions like HIT or thrombotic thrombocytopenic purpura 1
- Recommended for:
Activity restrictions:
- Patients with platelet counts <50 × 10³/μL should avoid trauma-associated activities 1
Special Considerations
Thrombocytopenia with thrombosis risk:
- Conditions like antiphospholipid syndrome, HIT, and thrombotic microangiopathies can present with both bleeding and thrombosis 1
- For suspected HIT, use the 4T score for clinical probability assessment:
- Thrombocytopenia (0-2 points)
- Timing of onset (0-2 points)
- Thrombosis or other sequelae (0-2 points)
- Other causes of thrombocytopenia (0-2 points) 3
- When HIT is confirmed, alternative anticoagulation should be initiated with direct thrombin inhibitors or factor Xa inhibitors 3
Pregnancy-associated thrombocytopenia:
- Consider gestational thrombocytopenia, preeclampsia, HELLP syndrome
- HELLP syndrome requires emergency hospitalization 1
Thrombocytopenia is a common hematologic finding that requires systematic evaluation to determine its cause and appropriate management. The severity of thrombocytopenia and presence of bleeding symptoms guide the urgency and intensity of intervention.